Parkinson's disease
Conditions
Interventions
the control group:Exclusive pharmacological treatment. Based on the condition, patients of the control group were given exclusive Western medication treatment, with each patient taking =3 types of ora
the Observation Group:Gua Sha combined with Western medication treatment. The Western medication treatment method is the same as that of the control group, and the specific Gua Sha method is described
Sponsors
Nanjing Hospital of traditional Chinese Medicine
Eligibility
Sex/Gender
All
Age
35 Years to 80 Years
Inclusion criteria
Inclusion criteria: 1. Meets the Western medical diagnostic criteria for Parkinson's Disease (PD); 2. Syndrome differentiation according to Traditional Chinese Medicine (TCM) standards; 3. Hoehn-Yahr staging = 2.5; 4. Disease duration of = 1 year; 5. Exclusive pharmacological treatment for PD with no more than two types of medications, with a stable dosage for = 30 days; 6. Voluntary participation with informed consent; 7. Good compliance and willing to cooperate with follow-up.
Exclusion criteria
Exclusion criteria: 1. Individuals with contraindications to Gua Sha, such as a tendency to bleed, blood system diseases, infectious skin diseases, extreme hunger or satiety, excessive thinness, or excessive fatigue; 2. Those who have undergone deep brain stimulation surgery; 3. Patients with severe brain, heart, liver, kidney, lung, or hematopoietic system diseases, and those with malignant tumors; 4. Individuals with mental disorders; 5. Those who are currently participating in or have participated in another clinical trial within the past 30 days.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Movement Disorder Society-Unified Parkinson’s Disease rating scale (MDS-UPDRS) score;Timed Up and Go Test (TUGT);Non-motor Symptoms Scale (NMSS) score;Plasma Inflammatory Cytokines;Therapeutic Efficacy Evaluation; | — |
Secondary
| Measure | Time frame |
|---|---|
| Parkinson’s disease Sleep Scale 2nd Version (PDSS-2) score;constipation scoring system (CSS) score;King’s Parkinson’s disease pain scale (KPPS) score;Parkinson Fatigue Scale (PFS-16) score;Hamilton Rating Scale for Anxiety (HAMA) score;24-item Hamilton Depression Scale (HAMD-24) score;the 39-item Parkinson’s Disease Questionnaire (PDQ-39) score; | — |
Countries
China
Contacts
Public ContactWang Qiuqin
Nanjing University of Chinese medicine
Outcome results
None listed